Community Health Systems Inc CYH

Health CareHealthcare Providers & ServicesUnited States of America

Last close 2.10 USD on Nov 2, 2026, −32.7% year to date

Quant rating

Quant rating C Rank 341 of 565 in Health Care

Growth B 108 of 565
Valuation B 175 of 565
Quality B 150 of 565
Revisions D 489 of 565
Momentum D 453 of 565

Wall Street consensus Hold (3.00)Average target 2.69 USD +28.3%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 296M
Enterprise value: 10.3B
52-week range: 2.09 – 3.92
3-year range: 2.09 – 6.22
Dividend yield: –
Beta (5 years): 1.90
Shares outstanding: 141M
Next earnings: Feb 16, 2027

About the company

Community Health Systems, Inc. is a healthcare company. The Company's affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 32 distinct markets across 12 states. Its subsidiaries own or lease 60 affiliated hospitals with more than 8,000 beds and operate more than 800 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. It provides a range of general and specialized hospital healthcare services and outpatient services. Services provided through its hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is its network of affiliated physicians at its hospitals and affiliated businesses.

Growth and profitability

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	12,485	12,634	12,490	12,211	12,368	–
Revenue growth	−1.2%	1.2%	2.3%	−1.3%	4.9%	1.2%
EPS (basic, normalized)	1.19	−1.03	−1.39	−1.38	2.45	–
EPS growth	–	–	–	–	–	–
Gross margin	85.1%	84.6%	84.0%	83.8%	83.5%	84.2%
Net margin	4.1%	−4.1%	−1.1%	0.4%	1.9%	0.2%
ROE	–	–	–	–	–	–

Balance sheet, last quarter
Cash & short-term investments (mil)	155
Current ratio	1.48x
Long-term debt (mil)	9,568
Net debt (mil)	9,986
Total equity (mil)	−1,492
Net debt / equity	−6.69x
Net debt / EBITDA	6.54x

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	12,485	−1.2%	0.8x	1,526	+0.4%	6.7x	1.19	+215.5%	1.8x
2026	11,372	−8.9%	0.9x	1,249	−18.2%	8.2x	−0.92	−177.1%	−2.3x
2027	11,348	−0.2%	0.9x	1,265	+1.3%	8.1x	−0.44	+52.5%	−4.8x
2028	11,660	+2.8%	0.9x	1,282	+1.4%	8.0x	−0.64	−47.5%	−3.3x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	11,372	−0.7%	−0.7%	−2.0%	−0.92	−7.5%	+4.3%	−62.6%
2027	11,348	−1.5%	−1.5%	−3.7%	−0.44	−47.4%	+14.3%	−1,144.5%
2028	11,660	−1.7%	−1.6%	−3.3%	−0.64	−82.3%	−79.0%	−280.9%

Earnings surprises EPS beat in 1 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter ended	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales reported (mil)	3,140	3,140	3,090	3,265	3,159	3,133	3,087	3,106	2,965	2,825
Sales mean (mil)	3,093	3,084	3,083	3,149	3,097	3,020	2,996	3,137	2,960	2,881
Surprise	+1.5%	+1.8%	+0.2%	+3.7%	+2.0%	+3.7%	+3.1%	−1.0%	+0.2%	−2.0%
EPS reported	−0.14	−0.17	−0.30	−0.42	−0.03	−0.05	1.27	−0.01	−0.48	−0.19
EPS mean	−0.16	−0.12	−0.18	0.08	−0.08	−0.10	−0.25	−0.10	−0.10	−0.06
Surprise	+13.4%	−40.9%	−63.3%	−613.1%	+62.2%	+52.1%	−615.7%	+90.4%	−392.3%	−204.0%

Peer comparison Healthcare Providers & Services

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
CYH Community Health Systems Inc	296M	6.54x	4.1%	−0.20x	−2.3x	−4.8x	8.2x	8.1x
UNH UnitedHealth Group Incorporated	359.4B	–	2.7%	3.45x	19.4x	17.1x	13.1x	11.9x
CVS CVS Health Corporation	113.2B	2.50x	0.4%	1.42x	11.0x	10.4x	8.3x	7.9x
HCA HCA Healthcare, Inc.	97.7B	3.41x	9.0%	−12.21x	15.6x	14.9x	9.5x	9.4x
ELV Elevance Health Inc	89.4B	–	2.8%	2.00x	14.2x	13.7x	10.0x	10.3x
CI The Cigna Group	78.0B	2.49x	2.2%	1.83x	9.7x	8.8x	7.7x	7.2x
Mean		3.74x	3.5%	−0.62x	11.3x	10.0x	9.5x	9.1x
Median		2.96x	2.8%	1.62x	12.6x	12.0x	8.9x	8.8x

Technical analysis

1M−22.8%
3M−24.7%
1Y−45.9%
3Y−10.3%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Community Health Systems Inc, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	12,485	12,634	12,490	12,211	12,368	11,789
Cost of revenue	1,864	1,946	1,993	1,975	2,042	1,963
Gross profit	10,621	10,688	10,497	10,236	10,326	9,826
Selling, general & administrative expenses	5,700	5,734	5,756	5,667	5,575	5,751
Research & development	–	–	–	–	–	–
Depreciation/amortization	426	486	505	534	540	558
Interest expense (income), operating	–	–	–	–	–	–
Unusual expense (income)	−503	276	−159	−355	−44.0	−866
Other operating expenses	3,413	3,625	3,366	3,316	2,932	2,940
Operating income	1,585	567	1,029	1,074	1,323	1,443
Net interest income (expense)	−861	−850	−822	−725	−824	−1,021
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	0	0	0	0	0	0
Net income before taxes	724	−283	207	349	499	422
Provision for taxes	48.0	79.0	191	170	131	−185
Minority interest	−167	−154	−149	−133	−138	−96.0
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	509	−516	−133	46.0	230	511
Extraordinary items	–	–	–	–	–	–
Net income	509	−516	−133	46.0	230	511
EBIT, normalized	1,091	895	940	730	1,279	577
EBITDA, normalized	1,517	1,381	1,445	1,264	1,819	1,135
Basic EPS, normalized	1.19	−1.03	−1.39	−1.38	2.45	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Community Health Systems Inc, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	260	37.0	38.0	118	507	1,676
Receivables	2,231	2,447	2,361	2,137	2,180	2,025
Total inventory	322	331	328	353	355	335
Prepaid expenses	194	289	336	336	286	234
Other current assets	227	197	145	138	151	240
Total current assets	3,234	3,301	3,208	3,082	3,479	4,510
Property, plant & equipment	5,120	5,399	5,872	6,103	6,221	5,964
Goodwill	3,316	3,789	3,958	4,166	4,219	4,219
Intangibles	42.0	53.0	61.0	52.0	–	–
Long-term investments	138	152	170	155	81.0	95.0
Note receivable	–	–	–	–	–	–
Other long-term assets	1,354	1,360	1,186	1,111	1,217	1,218
Total assets	13,204	14,054	14,455	14,669	15,217	16,006
Liabilities
Accounts payable	842	913	912	773	830	783
Payable/accrued	–	–	–	–	–	–
Accrued expenses	1,220	1,287	1,112	1,291	1,385	1,795
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	16.0	20.0	21.0	21.0	31.0	123
Other current liabilities	130	125	97.0	101	118	114
Total current liabilities	2,208	2,345	2,142	2,186	2,364	2,815
Long-term debt	10,380	11,432	11,466	11,614	12,109	12,093
Minority interest	557	597	568	633	562	571
Other liabilities	1,453	1,594	1,671	1,603	1,554	2,152
Total liabilities	14,598	15,968	15,847	16,036	16,589	17,631
Shareholders' equity
Preferred stock	0	0	0	0	0	–
Common stock	1.0	1.0	1.0	1.0	1.0	1.0
Additional paid-in capital	2,185	2,175	2,185	2,084	2,118	2,094
Retained earnings (accumulated deficit)	−3,571	−4,080	−3,564	−3,431	−3,477	−3,707
Treasury stock	–	–	–	–	–	–
Other equity	−9.0	−10.0	−14.0	−21.0	−14.0	−13.0
Total equity	−1,394	−1,914	−1,392	−1,367	−1,372	−1,625
Total liabilities & shareholders' equity	13,204	14,054	14,455	14,669	15,217	16,006

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Community Health Systems Inc, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	676	−362	16.0	179	368	607
Depreciation, depletion & amortization	426	486	505	534	540	558
Deferred taxes	−243	−116	35.0	165	170	−187
Non-cash items	−319	481	44.0	−99.0	167	−21.0
Changes in working capital	3.0	−9.0	−390	−479	−1,376	1,221
Cash from operations	543	480	210	300	−131	2,178
Investing activities
Capital expenditures	−335	−360	−467	−415	−469	−440
Other investing cash flows	1,182	85.0	441	156	−55.0	617
Cash from investing	847	−275	−26.0	−259	−524	177
Financing activities
Financing cash flow items	−181	−166	−140	−191	−453	−256
Cash dividends paid	–	–	–	–	–	–
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	−986	−40.0	−124	−239	−61.0	−639
Cash from financing	−1,167	−206	−264	−430	−514	−895
Foreign exchange effects	–	–	–	–	–	–
Net change in cash	223	−1.0	−80.0	−389	−1,169	1,460
Free cash flow	208	120	−257	−115	−600	1,738

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 2, 2026 after market close.